
Titolo | The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL. |
Publication Type | Journal Article |
Authors | Carinci, F, Monasta, L, Rubini, C, Stramazzotti, D, Palmieri, A, Melloni, E, Knowles, A, Ronfani, L, Zauli, G, Secchiero, P |
PubMed ID | 21086019 |